Ann Brady Theravance Biopharma, Inc. (TBPH) insider trading activity

Ann Brady is PRESIDENT, TBIL of Theravance Biopharma, Inc.. Currently has a direct ownership of 110,319 shares of TBPH, which is worth approximately $1.06 Million. The most recent transaction as insider was on Feb 18, 2022, when has been sold 8,369 shares (Ordinary Shares) at a price of $9.61 per share, resulting in proceeds of $80,426. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K

0% 3M change

0% 12M change

Total Value Held $1.06 Million

ANN BRADY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2022	SELL Payment of exercise price or tax liability	$80,426 $9.61 p/Share	8,369 Reduced 7.05%	110,319 Ordinary Shares
Nov 19 2021	SELL Payment of exercise price or tax liability	$26,493 $8.36 p/Share	3,169 Reduced 2.6%	118,688 Ordinary Shares
Aug 20 2021	SELL Payment of exercise price or tax liability	$44,524 $14.05 p/Share	3,169 Reduced 2.53%	121,857 Ordinary Shares
May 20 2021	SELL Payment of exercise price or tax liability	$56,408 $17.8 p/Share	3,169 Reduced 2.47%	125,026 Ordinary Shares
Feb 20 2021	SELL Payment of exercise price or tax liability	$189,629 $18.79 p/Share	10,092 Reduced 7.3%	128,195 Ordinary Shares
Feb 08 2021	BUY Grant, award, or other acquisition	-	40,000 Added 22.44%	138,287 Ordinary Shares
Nov 20 2020	SELL Payment of exercise price or tax liability	$39,445 $17.21 p/Share	2,292 Reduced 2.28%	98,287 Ordinary Shares

Ann Brady

PRESIDENT, TBIL

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Value

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH

Account